4.1 Pediatric & Neonatal Nutrition Assessment

4.1 Pediatric & Neonatal Nutrition Assessment

Clinical Core: Pediatric nutrition assessment requires distinct growth standards, age corrections, and specialized diagnostic criteria to evaluate acute wasting and chronic stunting. Preterm infants demand rigorous gestational age correction and aggressive nutrient provision to emulate intrauterine growth while preventing metabolic bone disease of prematurity. Understanding the physiological differences between descriptive references and prescriptive standards is essential for accurate clinical triage in this independent study resource.

---

Growth Standards in Pediatric Practice: WHO vs. CDC vs. Preterm Curves

Accurate pediatric anthropometric evaluation depends fundamentally on selecting the correct growth reference standard. Clinical errors frequently arise from conflating prescriptive standards (how children should grow under optimal conditions) with descriptive references (how children did grow in a specific historical cohort).

The World Health Organization (WHO) Growth Standards (0 to 24 Months)

The American Academy of Pediatrics (AAP) and the Centers for Disease Control and Prevention (CDC) mandate the use of the WHO Child Growth Standards for all infants and children from birth up to 24 months of age, regardless of ethnicity or socioeconomic status. The WHO standards were generated by the Multicentre Growth Reference Study (MGRS), which followed healthy children raised in environments supporting optimal physiological growth (including non-smoking mothers, adequate economic resources, and exclusive or predominant breastfeeding for at least 4 months, with complementary foods introduced by 6 months).

Because breastfed infants naturally gain weight rapidly in the first 2 to 3 months of life and subsequently slow their rate of weight gain compared to formula-fed infants, plotting a breastfed infant on historical formula-weighted charts falsely misclassifies normal breastfed infants as "faltering" or "failing to thrive" at 6 to 12 months. Conversely, the WHO standard provides an accurate biological benchmark that protects breastfed infants from unnecessary formula supplementation while correctly identifying pathological growth deceleration.

The CDC Growth Charts (2 to 20 Years)

For children aged 2 to 20 years, the CDC recommends transitioning to the 2000 CDC Growth Charts. These charts are descriptive population references derived from five cross-sectional National Health and Examination Surveys (NHANES) conducted between 1963 and 1994. Crucially, the CDC charts introduce Body Mass Index (BMI)-for-age percentiles beginning at 24 months of age:

$\text{BMI} = \frac{\text{Weight (kg)}}{[\text{Stature (m)}]^2}$

• Underweight: $< 5\text{th}$ percentile for age and sex.
• Healthy Weight: $5\text{th}$ to $< 85\text{th}$ percentile.
• Overweight: $85\text{th}$ to $< 95\text{th}$ percentile.
• Obese: $\ge 95\text{th}$ percentile (or $\text{BMI} \ge 30\text{ kg/m}^2$, whichever is lower).

Specialized Preterm Growth Curves: Fenton and Olsen

Infants born preterm ($< 37\text{ weeks}$ completed gestation) experience an abrupt cessation of placental nutrient delivery during the critical third-trimester window of rapid nutrient accretion. Term growth charts are clinically invalid for these infants until they reach term-equivalent age. Clinicians utilize specialized intrauterine growth curves:

1. Fenton 2013 Preterm Growth Curves: A widely adopted growth curve based on a meta-analysis of nearly 4 million births from developed nations (Germany, United States, Italy, Australia, Canada, Scotland). It plots weight, length, and head circumference from 22 weeks gestational age up to 50 weeks postmenstrual age, harmonizing directly with the WHO growth standards at 50 weeks.
2. Olsen 2010 Curves: Derived from a diverse United States cohort of 391,681 singleton infants born between 22 and 42 weeks gestation. Olsen curves provide precise day-by-day intrauterine growth percentiles.

---

Corrected Gestational Age (CGA) and Developmental Plotting

Premature infants must not be evaluated against chronological milestones without correcting for their degree of prematurity. Failing to apply Corrected Gestational Age (CGA)—also referred to as adjusted age—results in false diagnoses of failure to thrive, inappropriate microcephaly alerts, parental distress, and hazardous overfeeding.

Formula for Corrected Gestational Age

$\text{Weeks of Prematurity} = 40\text{ weeks} - \text{Gestational Age at Birth (weeks)}$

$\text{Corrected Age (weeks)} = \text{Chronological Age (weeks)} - \text{Weeks of Prematurity}$

$\text{Corrected Age} = \text{Chronological Age (weeks)} - (40 - \text{Gestational Age at Birth [weeks]})$

Clinical Calculation Example

An infant is born at $28\text{ weeks}$ gestation. Today, the infant presents to the outpatient clinic at a chronological age of $16\text{ weeks}$ (approximately 4 months since birth):

1. Calculate Weeks of Prematurity: $\text{Prematurity} = 40 - 28 = 12\text{ weeks}$
2. Calculate Corrected Gestational Age: $\text{Corrected Age} = 16\text{ weeks} - 12\text{ weeks} = 4\text{ weeks} \text{ (1 month)}$

Clinical Interpretation: Although the infant has been out of the womb for 16 weeks, their physiological and neurological development aligns with a 4-week-old full-term infant. All anthropometric parameters (weight, length, and head circumference) must be plotted at the 4-week mark on the WHO growth charts.

Clinical Duration of Age Correction

Current pediatric consensus dictates that CGA must be applied for anthropometric plotting and developmental milestones until $24\text{ to }36\text{ months}$ of life. Weight typically demonstrates catch-up by 24 months, whereas linear length, head circumference, and complex neurocognitive development in extremely low birth weight infants may require correction through 36 months.

---

Core Anthropometric Metrics and Z-Score Transformations

In pediatric populations, absolute values for body weight and height are clinically uninterpretable without contextualizing against age and sex. While percentiles are widely understood by caregivers, they possess major mathematical limitations at the statistical extremes.

Z-Scores (Standard Deviation Scores)

A z-score expresses an individual anthropometric measurement as the number of standard deviations ($\sigma$) it deviates from the reference population mean ($\mu$):

$z = \frac{X - \mu}{\sigma}$

• Superiority Over Percentiles: Percentile curves compress at the distribution tails. The 3rd percentile corresponds to $z = -1.88$, and the 1st percentile corresponds to $z = -2.33$. Any measurement falling below the 1st percentile is grouped indistinguishably as "$<1\text{st}$ percentile". However, in severe clinical malnutrition, a patient with a z-score of $-2.5$ has a vastly different metabolic status and mortality risk than a patient with a z-score of $-4.5$. Z-scores quantify precise changes over time, facilitating accurate tracking of nutritional rehabilitation.

Key Anthropometric Indices

1. Weight-for-Age (WFA): Reflects total body mass relative to chronological age. Highly sensitive to acute fluid shifts, dehydration, and rapid wasting, but cannot differentiate whether a low weight is due to acute fat/muscle loss (wasting) or stunted linear stature (chronic malnutrition).
2. Weight-for-Length (WFL, $<24$ Months) / BMI-for-Age ($\ge 24$ Months): The gold standard indicators of acute nutritional status and body proportionality. Low WFL or BMI-for-age indicates acute malnutrition (wasting).
3. Length/Height-for-Age (LFA/HFA): Evaluates linear skeletal elongation. Deficits reflect chronic malnutrition (stunting), long-standing endocrine abnormalities, or persistent systemic inflammation.
4. Occipital Frontal Circumference (OFC): Directly reflects cranial bone expansion and intracranial brain volume during the first 36 months of life. It is measured at the maximum circumference passing across the supraorbital ridges and the prominent occipital protuberance.
   • The Physiology of Brain Sparing: During acute starvation or nutrient deprivation, the infant body activates neuroendocrine survival mechanisms. Endogenous glucose, amino acids, and cardiac output are prioritized to the cerebral circulation, preserving brain cell replication and myelin deposition at the expense of somatic fat depots, skeletal muscle, and linear bone elongation. As acute starvation sets in, weight falls first, length deceleration follows second, and OFC is preserved last.
   • Microcephaly: When an infant presents with a significantly depressed OFC z-score ($z < -2.0\text{ or } \le -3.0$) secondary to nutritional deficiency, it indicates severe, protracted, chronic malnutrition where adaptive brain-sparing mechanisms have broken down, placing the infant at high risk for irreversible cognitive, motor, and neurosensory deficits.
5. Mid-Upper Arm Circumference (MUAC): Validated in children aged 6 to 59 months. MUAC evaluates somatic skeletal muscle and subcutaneous adipose tissue. Unlike weight, MUAC is relatively preserved in the presence of dependent pedal edema or ascites, making it a vital diagnostic tool in fluid-overloaded children with nephrotic syndrome, liver failure, or congenital heart disease.

---

Pediatric Malnutrition Consensus Criteria (AND/ASPEN 2014)

The Academy of Nutrition and Dietetics (AND) and the American Society for Parenteral and Enteral Nutrition (ASPEN) established a standardized pediatric malnutrition (undernutrition) diagnostic consensus based on etiology, chronicity, and anthropometric z-score deviations.

Etiological Classification: Primary vs. Secondary

• Primary Malnutrition (Non-Illness-Related): Driven by environmental, behavioral, or socioeconomic deprivations with no active systemic inflammation. Examples include severe food insecurity, improper infant formula reconstitution (over-dilution), intractable feeding behavioral aversions, or caregiver neglect.
• Secondary Malnutrition (Illness-Related): Driven by an underlying disease or trauma characterized by increased nutrient requirements, malabsorption, elevated metabolic expenditure, or sustained systemic inflammation. Common clinical etiologies include congenital heart disease (CHD), cystic fibrosis, short bowel syndrome, severe pediatric burns, chronic renal disease, and pediatric oncology.

Diagnostic Z-Score Matrix

---

Neonatal and Preterm Nutrition Support Requirements

Preterm infants, particularly Very Low Birth Weight (VLBW, $<1,500\text{ g}$) and Extremely Low Birth Weight (ELBW, $<1,000\text{ g}$) infants, are born with practically zero adipose reserves, minimal glycogen stores, and immature organ systems. They exhibit the highest nutrient requirements per kilogram of any human population.

Fluid Requirements

Preterm infants have disproportionately high insensible fluid losses through their gelatinous, non-keratinized skin (impaired stratum corneum), amplified by radiant warmers and phototherapy units. Fluid management balances hydration against the risks of patent ductus arteriosus (PDA), bronchopulmonary dysplasia (BPD), and necrotizing enterocolitis (NEC):

• Initial Day 1–2: $60\text{--}80\text{ mL/kg/day}$ of $10\%$ dextrose in water.
• Maintenance Goal: $120\text{--}150\text{ mL/kg/day}$ (may reach $160\text{--}180\text{ mL/kg/day}$ in ELBW infants under phototherapy).

Energy Goals

• Parenteral Nutrition: $90\text{--}110\text{ kcal/kg/day}$ (bypasses digestive and fecal losses).
• Enteral Nutrition: $110\text{--}130\text{ kcal/kg/day}$ (up to $140\text{ kcal/kg/day}$ in infants with chronic lung disease / BPD).
• Target Weight Gain Velocity: $15\text{--}20\text{ g/kg/day}$ for gestations $<34$ weeks to emulate the third-trimester intrauterine growth rate.

Protein Requirements and Amino Acid Specialization

Fasting preterm infants rapidly lose endogenous protein. Current ASPEN guidance recommends prompt initiation of PN after appropriate vascular access is obtained. An initial amino-acid dose above $3\text{ g/kg/day}$ is not recommended; the usual target is $3\text{ to }3.5\text{ g/kg/day}$, without exceeding $3.5\text{ g/kg/day}$. Growth, blood urea nitrogen, acid-base status, renal function, and overall clinical tolerance guide individual adjustment.

Neonates have immature hepatic transsulfuration and urea cycle enzyme pathways, rendering several amino acids conditionally essential:

1. Cysteine: Preterm infants exhibit negligible cystathionase activity, making them unable to synthesize cysteine from methionine. Supplementation with L-cysteine hydrochloride may be prescribed according to the amino-acid product, patient needs, compatibility, and current product availability; it is not a universal fixed-dose mandate. Cysteine contributes to endogenous glutathione (antioxidant) synthesis and hepatic bile acid conjugation. Crucially, adding L-cysteine HCl acidifies the parenteral nutrition solution, which directly enhances the chemical solubility of calcium and phosphorus salts.
2. Taurine: Immature cystathionine $\gamma$-lyase and cysteine sulfinic acid decarboxylase pathways impede taurine synthesis. Taurine is required for bile acid conjugation (taurocholic acid) and retinal photoreceptor and neurocerebral membrane development.
3. Arginine: Limited intestinal synthesis and low argininosuccinate synthetase activity necessitate exogenous arginine to prevent hyperammonemia and stimulate microvascular endothelial nitric oxide synthesis, reducing the risk of necrotizing enterocolitis (NEC).
4. Tyrosine: Low phenylalanine hydroxylase activity limits conversion of phenylalanine to tyrosine.

Calcium-to-Phosphorus Homeostasis and Metabolic Bone Disease of Prematurity

Approximately $80\%$ of fetal bone mineral accretion occurs during the third trimester between 24 and 37 weeks of gestation ($120\text{--}150\text{ mg/kg/day}$ calcium and $60\text{--}80\text{ mg/kg/day}$ phosphorus transferred across the placenta). Preterm birth abruptly interrupts this process, placing premature infants at severe risk for Metabolic Bone Disease of Prematurity (MBDP), also known as osteopenia or rickets of prematurity.

• Biochemical Markers: Hypophosphatemia ($< 4.0\text{ mg/dL}$ or $< 1.3\text{ mmol/L}$), markedly elevated serum alkaline phosphatase ($> 800\text{--}1,000\text{ IU/L}$), and elevated parathyroid hormone (PTH).
• Parenteral Target Ratios:
  • Molar Ratio: $1.7:1\text{ to }2.0:1$ ($\text{Ca}:\text{P}$).
  • Weight Ratio: $1.3:1\text{ to }1.7:1$ ($\text{Ca}:\text{P}$ in mg).
• Dosing and Compounding Precautions: After the first few days of life, a calcium-to-phosphorus molar ratio of about 1:1 to 1.3:1 generally supports mineral retention, but absolute doses and the ratio must be individualized for serum values, renal function, growth, and refeeding risk. Compatibility is limited by precipitation of insoluble dibasic calcium phosphate ($\text{CaHPO}_4$). Lower pH, adequate amino-acid concentration, lower temperature, and calcium gluconate rather than calcium chloride improve solubility; the pharmacist must verify the exact formulation.